HAT-SIL-TG-1&AT
HAT-SIL-TG-1&AT is a hypoxia-activated prodrug that acts as a Janus kinase (JAK) inhibitor. It exerts antitumor effects by blocking the JAK-STAT pathway, suppressing HEL cell proliferation and reducing phospho-STAT3/5 levels under hypoxia, making it a tool for studying hypoxia-targeted oncology research.
Product Specifications
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Molecular Formula
C60H69N17O11S
Molecular Weight
1236.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
